RARE - CIK 0001515673
As of 2026-06-10, Ultragenyx Pharmaceutical Inc. (RARE) has a market capitalization of $2.26 B, making it the #2014 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $2.26 B |
| 2026-05-29 | $2.34 B |
| 2026-05-28 | $2.30 B |
| 2026-05-26 | $2.31 B |
| 2026-05-25 | $2.30 B |
| 2026-05-24 | $2.30 B |
| 2026-05-22 | $2.30 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, Ultragenyx Pharmaceutical Inc. (RARE) has a market capitalization of $2.26 B, making it the #2014 most valuable US-listed company.
Ultragenyx Pharmaceutical Inc. is the #2014 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.